Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Made-to-measure treatment battling colon cancer by computer

21.04.2006


Colon cancer treatment could be revolutionised with a pioneering computer system to help doctors fight the disease.



Colon cancer is the third biggest killer cancer and the £2 million EU-funded project could mean faster and more accurate diagnosis, leading to better treatment outcomes for patients.

The system identifies gene mutations that contribute to the growth of cancerous tumours, giving doctors vital details about the type of cancer and its possible causes. It works by matching information from a simple blood test to gene databases of other cases, equipping doctors with a valuable tool to make decisions on long-term care.


It helps them determine the most effective way to battle the condition and, by speeding up the time to make treatment decisions, it will boost survival rates and reduce costs incurred by inaccurate diagnosis. It also means patients will no longer need to undergo invasive procedures unnecessarily.

The project has been masterminded by a team across the EU, comprising leading computer experts working alongside cancer specialists, biomedical scientists and genetic engineers.

It heralds the first major step towards tailor-made, personalised medical treatment.

Dr Babak Akhgar leads the seven-strong team working on the project, in the University’s Cultural, Communication and Computing Research Institute. He said: "It’s very exciting. It is potentially a defining IT project for the future of cancer care and is a huge step towards cutting cancer rates across the board because once the system is established it can be adapted to be applied to other cancers. There’s a real chance of helping save lives. It harnesses the know-how in this field across Europe, bringing it to the desktop of any healthcare professional. It means treatment is backed up by hard facts, rather than reliant on a specialist’s interpretation and experience alone.

"It will be the first breakthrough in personalised medicine. It’s like being able to take a tablet not just for symptom relief, but to treat the exact illness you have. This paves the way for 25th century drugs that are tailor-made to treat an individual’s problems, rather than mass-produced drugs for all."

Sheffield Hallam University is one of eight research partners from across Europe working on the project, called MATCH. The state-of-the-art technology could be in use in hospitals within five years.

The next phase of MATCH is collecting data from colon cancer patient databases in Italy and Poland, which will be fed into the system and tested.

Pharmaceutical firms will also be brought into the project to feed into talks on potential new drug design and discoveries.

Kelly Hill | alfa
Further information:
http://www.shu.ac.uk/news

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

Shape matters when light meets atom

05.12.2016 | Physics and Astronomy

Researchers uncover protein-based “cancer signature”

05.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>